Abeona Therapeutics Incの内部者の所有権
Abeona Therapeutics Incの内部者の所有権は何ですか。
Abeona Therapeutics Incの内部者の所有権は11.37%です。
内部者の所有権の定義は何ですか。
管理の所有権(Insider Ownership)は、発行済株式総数で除したインサイダー（5％超を所有する株主または取締役または役員) が所有する株式総数によって計算されます。
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
NASDAQのセクタHealth Careにおける内部者の所有権の企業と比べるAbeona Therapeutics Inc
Abeona Therapeutics Incは何をしますか。
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
Abeona Therapeutics Incと類似の内部者の所有権
- Ramaco Resources Incの内部者の所有権は11.36%です。
- QMC Quantum Minerals Corpの内部者の所有権は11.36%です。
- Catalyst Biosciences Incの内部者の所有権は11.36%です。
- Palantir Technologiesの内部者の所有権は11.36%です。
- Zenithの内部者の所有権は11.37%です。
- Aptitude Software plcの内部者の所有権は11.37%です。
- Abeona Therapeutics Incの内部者の所有権は11.37%です。
- Life360の内部者の所有権は11.38%です。
- Dalata Hotel plcの内部者の所有権は11.38%です。
- Roth CH Acquisition I Coの内部者の所有権は11.38%です。
- Copper Lake Resourcesの内部者の所有権は11.38%です。
- Copper Lake Resourcesの内部者の所有権は11.38%です。
- SBIの内部者の所有権は11.39%です。